標(biāo)題: Titlebook: Chemotherapy and Radiotherapy of Gastrointestinal Tumors; Hans Otto Klein Book 1981 Springer-Verlag Berlin Heidelberg 1981 Chemotherapy.Ra [打印本頁(yè)] 作者: 我贊成 時(shí)間: 2025-3-21 16:36
書目名稱Chemotherapy and Radiotherapy of Gastrointestinal Tumors影響因子(影響力)
書目名稱Chemotherapy and Radiotherapy of Gastrointestinal Tumors影響因子(影響力)學(xué)科排名
書目名稱Chemotherapy and Radiotherapy of Gastrointestinal Tumors網(wǎng)絡(luò)公開(kāi)度
書目名稱Chemotherapy and Radiotherapy of Gastrointestinal Tumors網(wǎng)絡(luò)公開(kāi)度學(xué)科排名
書目名稱Chemotherapy and Radiotherapy of Gastrointestinal Tumors被引頻次
書目名稱Chemotherapy and Radiotherapy of Gastrointestinal Tumors被引頻次學(xué)科排名
書目名稱Chemotherapy and Radiotherapy of Gastrointestinal Tumors年度引用
書目名稱Chemotherapy and Radiotherapy of Gastrointestinal Tumors年度引用學(xué)科排名
書目名稱Chemotherapy and Radiotherapy of Gastrointestinal Tumors讀者反饋
書目名稱Chemotherapy and Radiotherapy of Gastrointestinal Tumors讀者反饋學(xué)科排名
作者: CRUMB 時(shí)間: 2025-3-21 20:49
https://doi.org/10.1007/978-3-642-19146-61973. There are now 39 institutions in the Netherlands, Germany, Switzerland, Italy, Spain, France, Israel, and Belgium contributing to the various clinical trials. They have already registered 1,350 patients, of whom 950 are evaluable for the studies. Seven clinical trials are still in progress or 作者: 寬敞 時(shí)間: 2025-3-22 03:11 作者: 重畫只能放棄 時(shí)間: 2025-3-22 05:54
https://doi.org/10.1007/978-3-642-19199-2” surgery alone often proves inadequate, many types of postoperative adjuvant procedures have been applied in an attempt to improve the long-term survival rates. Systemic adjuvant therapy generally consists of either chemotherapy or immunotherapy, and after radical surgery, the 5-year survival rates作者: 符合你規(guī)定 時(shí)間: 2025-3-22 12:08
On a Change of SU(3) into Three SU(2),U(1)azoxane. Thirty-one patients were Duke’s group A; 49 group B; 61 group C; and 17 group D; an additional four patients were randomized in error..The adjuvant group received the usual clinical care and 125 mg razoxane twice daily for 5 consecutive days (Monday–friday) every week indefinitely. Control 作者: Obituary 時(shí)間: 2025-3-22 13:39
https://doi.org/10.1007/978-3-642-19199-2new cases of malignant RS tumors were diagnosed; of these, 1,103 were in males, representing 6% of all male malignant tumors (incidence per 100,000 = 22.6). In females, 864 new cases were diagnosed, representing 5.1% of all female tumors (incidence per 100,000 = 16.3).作者: Obituary 時(shí)間: 2025-3-22 19:43
On a Change of SU(3) into Three SU(2),U(1)orouracil (5-FU) [31, 32]. Furthermore, the reported long serum half-life of ftorafur of approximately 10–16 h for the beta-phase [1, 4, 10, 19, 20] makes the drug interesting for split-dose schedules. In comparison with single daily injections, split-dose administration of a drug with a long serum 作者: CRAFT 時(shí)間: 2025-3-23 00:01 作者: Carminative 時(shí)間: 2025-3-23 01:38 作者: 發(fā)酵劑 時(shí)間: 2025-3-23 09:03
Geometrical Properties of the U(1) Gaugeexpected. For this reason a comparative pharmacokinetic study of intravenous versus oral application was performed on six patients, as well as a pilot study on 13 patients with adenocarcinomas of different origins. The results show that 5-FU is absorbed rapidly. The biological availability increases作者: corpus-callosum 時(shí)間: 2025-3-23 10:54
https://doi.org/10.1007/978-3-642-81681-9Chemotherapy; Radiotherapy; Tumor; Tumors; therapy; Radiaton Oncology作者: Panther 時(shí)間: 2025-3-23 14:30
978-3-642-81683-3Springer-Verlag Berlin Heidelberg 1981作者: 合群 時(shí)間: 2025-3-23 18:14 作者: 信條 時(shí)間: 2025-3-24 00:40
Why Do Colon Tumours Respond Poorly to Chemotherapeutic Agents?,In theory any of the following mechanisms, singly or in combination, may form the basis of a poor response to cytostatic agents:作者: LINE 時(shí)間: 2025-3-24 04:13
Recent Results in Cancer Researchhttp://image.papertrans.cn/c/image/224968.jpg作者: 原來(lái) 時(shí)間: 2025-3-24 08:46
Methyl-CCNU and Ftorafur in Treatment of Rectosigmoidal Tumors and Ftorafur Capsules in Treatment onew cases of malignant RS tumors were diagnosed; of these, 1,103 were in males, representing 6% of all male malignant tumors (incidence per 100,000 = 22.6). In females, 864 new cases were diagnosed, representing 5.1% of all female tumors (incidence per 100,000 = 16.3).作者: 手工藝品 時(shí)間: 2025-3-24 14:42
Chemotherapy and Radiotherapy of Gastrointestinal Tumors978-3-642-81681-9Series ISSN 0080-0015 Series E-ISSN 2197-6767 作者: dysphagia 時(shí)間: 2025-3-24 15:29 作者: AXIOM 時(shí)間: 2025-3-24 19:45
The Importance of Lectin Binding Sites and Carcinoembryonic Antigen with Regard to Normal, Hyperplaarcinomas than in normal mucosa. The lectin binding pattern of adenomas was similar to that of the transitional mucosa. However, in proliferating parts and areas with cell atypia the amount of lectin receptors was generally reduced. In colonic carcinomas the occurrence of lectin receptors was correl作者: 尖叫 時(shí)間: 2025-3-24 23:50 作者: 半圓鑿 時(shí)間: 2025-3-25 05:51 作者: nettle 時(shí)間: 2025-3-25 09:46
Effectiveness of Postoperative Adjuvant Therapy with Cytotoxic Chemotherapy (Cytosine Arabinoside, ” surgery alone often proves inadequate, many types of postoperative adjuvant procedures have been applied in an attempt to improve the long-term survival rates. Systemic adjuvant therapy generally consists of either chemotherapy or immunotherapy, and after radical surgery, the 5-year survival rates作者: 供過(guò)于求 時(shí)間: 2025-3-25 14:27
A Controlled Prospective Trial of Adjuvant Razoxane in Resectable Colorectal Cancer,azoxane. Thirty-one patients were Duke’s group A; 49 group B; 61 group C; and 17 group D; an additional four patients were randomized in error..The adjuvant group received the usual clinical care and 125 mg razoxane twice daily for 5 consecutive days (Monday–friday) every week indefinitely. Control 作者: 隱士 時(shí)間: 2025-3-25 18:54
Methyl-CCNU and Ftorafur in Treatment of Rectosigmoidal Tumors and Ftorafur Capsules in Treatment onew cases of malignant RS tumors were diagnosed; of these, 1,103 were in males, representing 6% of all male malignant tumors (incidence per 100,000 = 22.6). In females, 864 new cases were diagnosed, representing 5.1% of all female tumors (incidence per 100,000 = 16.3).作者: Immunoglobulin 時(shí)間: 2025-3-25 22:34 作者: 大雨 時(shí)間: 2025-3-26 03:18 作者: Chauvinistic 時(shí)間: 2025-3-26 07:59 作者: Cougar 時(shí)間: 2025-3-26 08:55
5-Fluorouracil: A Comparative Pharmacokinetic Study and Preliminary Results of a Clinical Phase I Sexpected. For this reason a comparative pharmacokinetic study of intravenous versus oral application was performed on six patients, as well as a pilot study on 13 patients with adenocarcinomas of different origins. The results show that 5-FU is absorbed rapidly. The biological availability increases作者: 吸引人的花招 時(shí)間: 2025-3-26 13:04 作者: 脫離 時(shí)間: 2025-3-26 17:16 作者: 身體萌芽 時(shí)間: 2025-3-27 00:12
On a Change of SU(3) into Three SU(2),U(1)espective of whether they were cured by surgery (Duke’s A), had advanced cancer (Duke’s D), or took no razoxane when randomized to take it, then as might be expected any differences there may be between the razoxane-treated and control patients with minimal residual disease (Duke’s B and C) are so d作者: 使熄滅 時(shí)間: 2025-3-27 04:39 作者: exercise 時(shí)間: 2025-3-27 08:38 作者: Accommodation 時(shí)間: 2025-3-27 12:51
A Controlled Prospective Trial of Adjuvant Razoxane in Resectable Colorectal Cancer,espective of whether they were cured by surgery (Duke’s A), had advanced cancer (Duke’s D), or took no razoxane when randomized to take it, then as might be expected any differences there may be between the razoxane-treated and control patients with minimal residual disease (Duke’s B and C) are so d作者: musicologist 時(shí)間: 2025-3-27 13:43
Chemotherapy and Radiotherapy of Gastrointestinal Tumors作者: 華而不實(shí) 時(shí)間: 2025-3-27 18:17 作者: 使出神 時(shí)間: 2025-3-27 23:52
0080-0015 e tumours induce [6, 8, 11]. The drug is not cytotoxic in the usual sense, does not affect non-dividing cells, and only blocks cell division during a brief peri978-3-642-81683-3978-3-642-81681-9Series ISSN 0080-0015 Series E-ISSN 2197-6767 作者: Connotation 時(shí)間: 2025-3-28 03:16
Book 1981nt prognostic groups [4] and the paucity of drugs that have shown activity in the advanced disease [10]. Of the few drugs which are active in the advanced disease, only 5-fluorouracil (5-FU) and razoxane ?±1,2-bis(3,4-dioxopiperazin-1-yl)propane) are suitable for long-term adjuvant treatment [2, 9].作者: Pathogen 時(shí)間: 2025-3-28 06:32
On a Change of SU(3) into Three SU(2),U(1)half-life may offer the advantage of maintaining a higher level of cytocidal activity over a longer period of time without the problem of serious side effects, especially in the nervous system, as can be observed after a single high-dose injection of ftorafur [27].作者: Spinous-Process 時(shí)間: 2025-3-28 13:19 作者: 擔(dān)心 時(shí)間: 2025-3-28 15:52 作者: Erythropoietin 時(shí)間: 2025-3-28 21:00
https://doi.org/10.1007/978-3-642-19146-6inical trials. They have already registered 1,350 patients, of whom 950 are evaluable for the studies. Seven clinical trials are still in progress or already closed. The purpose of this paper is to review these studies briefly.作者: Cholagogue 時(shí)間: 2025-3-29 00:49 作者: Minikin 時(shí)間: 2025-3-29 03:08
Geometrical Properties of the U(1) Gauge 5-Fluorouracil (5-FU), the standard agent for this disease, has a response rate of 20% at best [3], and the response rate falls to 10% if stringent criteria for hepatic response are applied [4]. combinations.作者: 愛(ài)花花兒憤怒 時(shí)間: 2025-3-29 09:57 作者: bronchodilator 時(shí)間: 2025-3-29 13:57 作者: 頂點(diǎn) 時(shí)間: 2025-3-29 17:03
Efficacy of Dacarbazine Imidazole Carboxamide and Mitomycin C Combination Therapy in Patients with 5-Fluorouracil (5-FU), the standard agent for this disease, has a response rate of 20% at best [3], and the response rate falls to 10% if stringent criteria for hepatic response are applied [4]. combinations.
